CERA

Science and Research

MYLITE: A 52-week multicenter, randomized, double-masked, 2-arm parallel study to compare efficacy, safety and immunogenicity of SOK583A1 to Eylea®, administered intravitreally, in patients with neovascular age-related macular degeneration

Overview

  • Principal Investigator
Associate Professor Sanj Wickremasinghe